Literature DB >> 27481239

A Coccidioides posadasii CPS1 Deletion Mutant Is Avirulent and Protects Mice from Lethal Infection.

Hema P Narra1, Lisa F Shubitz2, M Alejandra Mandel3, Hien T Trinh2, Kurt Griffin4, Adam S Buntzman4, Jeffrey A Frelinger5, John N Galgiani6, Marc J Orbach7.   

Abstract

The CPS1 gene was identified as a virulence factor in the maize pathogen Cochliobolus heterostrophus Hypothesizing that the homologous gene in Coccidioides posadasii could be important for virulence, we created a Δcps1 deletion mutant which was unable to cause disease in three strains of mice (C57BL/6, BALB/c, or the severely immunodeficient NOD-scid,γc(null) [NSG]). Only a single colony was recovered from 1 of 60 C57BL/6 mice following intranasal infections of up to 4,400 spores. Following administration of very high doses (10,000 to 2.5 × 10(7) spores) to NSG and BALB/c mice, spherules were observed in lung sections at time points from day 3 to day 10 postinfection, but nearly all appeared degraded with infrequent endosporulation. Although the role of CPS1 in virulence is not understood, phenotypic alterations and transcription differences of at least 33 genes in the Δcps1 strain versus C. posadasii is consistent with both metabolic and regulatory functions for the gene. The in vitro phenotype of the Δcps1 strain showed slower growth of mycelia with delayed and lower spore production than C. posadasii, and in vitro spherules were smaller. Vaccination of C57BL/6 or BALB/c mice with live Δcps1 spores either intranasally, intraperitoneally, or subcutaneously resulted in over 95% survival with mean residual lung fungal burdens of <1,000 CFU from an otherwise lethal C. posadasii intranasal infection. Considering its apparently complete attenuation of virulence and the high degree of resistance to C. posadasii infection when used as a vaccine, the Δcps1 strain is a promising vaccine candidate for preventing coccidioidomycosis in humans or other animals.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27481239      PMCID: PMC5038059          DOI: 10.1128/IAI.00633-16

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  Genetic transformation of Coccidioides immitis facilitated by Agrobacterium tumefaciens.

Authors:  R O Abuodeh; M J Orbach; M A Mandel; A Das; J N Galgiani
Journal:  J Infect Dis       Date:  2000-06-05       Impact factor: 5.226

2.  Immunity to coccidioi-domycosis induced in mice by purified spherule, arthrospore, and mycelial vaccines.

Authors:  H B LEVINE; J M COBB; C E SMITH
Journal:  Trans N Y Acad Sci       Date:  1960-04

3.  Improved protection of mice against lethal respiratory infection with Coccidioides posadasii using two recombinant antigens expressed as a single protein.

Authors:  Lisa F Shubitz; Jieh-Juen Yu; Chiung-Yu Hung; Theo N Kirkland; Tao Peng; Robert Perrill; Julie Simons; Jianmin Xue; Roger A Herr; Garry T Cole; John N Galgiani
Journal:  Vaccine       Date:  2006-04-18       Impact factor: 3.641

4.  NUTRITION OF THE PARASITIC PHASE OF COCCIDIOIDES IMMITIS IN A CHEMICALLY DEFINED LIQUID MEDIUM.

Authors:  J L Converse; A R Besemer
Journal:  J Bacteriol       Date:  1959-08       Impact factor: 3.490

Review 5.  Humanized mice for immune system investigation: progress, promise and challenges.

Authors:  Leonard D Shultz; Michael A Brehm; J Victor Garcia-Martinez; Dale L Greiner
Journal:  Nat Rev Immunol       Date:  2012-10-12       Impact factor: 53.106

6.  DIP2 disco-interacting protein 2 homolog A (Drosophila) is a candidate receptor for follistatin-related protein/follistatin-like 1--analysis of their binding with TGF-β superfamily proteins.

Authors:  Masao Tanaka; Kosaku Murakami; Shoichi Ozaki; Yoshitaka Imura; Xiao-Peng Tong; Takuo Watanabe; Toshioki Sawaki; Takafumi Kawanami; Daisuke Kawabata; Takao Fujii; Takashi Usui; Yasufumi Masaki; Toshihiro Fukushima; Zhe-Xiong Jin; Hisanori Umehara; Tsuneyo Mimori
Journal:  FEBS J       Date:  2010-09-22       Impact factor: 5.542

7.  Biogeographic range expansion into South America by Coccidioides immitis mirrors New World patterns of human migration.

Authors:  M C Fisher; G L Koenig; T J White; G San-Blas; R Negroni; I G Alvarez; B Wanke; J W Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-03       Impact factor: 11.205

8.  Cloning, genomic organization and expression pattern of a novel Drosophila gene, the disco-interacting protein 2 (dip2), and its murine homolog.

Authors:  M Mukhopadhyay; P Pelka; D DeSousa; B Kablar; A Schindler; M A Rudnicki; A R Campos
Journal:  Gene       Date:  2002-06-26       Impact factor: 3.688

9.  Modeling nikkomycin Z dosing and pharmacology in murine pulmonary coccidioidomycosis preparatory to phase 2 clinical trials.

Authors:  Lisa F Shubitz; Hien T Trinh; Robert H Perrill; C Michael Thompson; Nathan J Hanan; John N Galgiani; David E Nix
Journal:  J Infect Dis       Date:  2014-01-12       Impact factor: 5.226

10.  Phylogenomics reveals subfamilies of fungal nonribosomal peptide synthetases and their evolutionary relationships.

Authors:  Kathryn E Bushley; B Gillian Turgeon
Journal:  BMC Evol Biol       Date:  2010-01-26       Impact factor: 3.260

View more
  22 in total

1.  CARD9-Associated Dectin-1 and Dectin-2 Are Required for Protective Immunity of a Multivalent Vaccine against Coccidioides posadasii Infection.

Authors:  Althea Campuzano; Hao Zhang; Gary R Ostroff; Lucas Dos Santos Dias; Marcel Wüthrich; Bruce S Klein; Jieh-Juen Yu; Humberto H Lara; Jose L Lopez-Ribot; Chiung-Yu Hung
Journal:  J Immunol       Date:  2020-05-01       Impact factor: 5.422

Review 2.  Early Events in Coccidioidomycosis.

Authors:  Fariba M Donovan; Lisa Shubitz; Daniel Powell; Marc Orbach; Jeffrey Frelinger; John N Galgiani
Journal:  Clin Microbiol Rev       Date:  2019-10-16       Impact factor: 26.132

3.  DIP2 is a unique regulator of diacylglycerol lipid homeostasis in eukaryotes.

Authors:  Sudipta Mondal; Priyadarshan Kinatukara; Shubham Singh; Sakshi Shambhavi; Gajanan S Patil; Noopur Dubey; Salam Herojeet Singh; Biswajit Pal; P Chandra Shekar; Siddhesh S Kamat; Rajan Sankaranarayanan
Journal:  Elife       Date:  2022-06-29       Impact factor: 8.713

4.  Viable spores of Coccidioides posadasii Δcps1 are required for vaccination and provide long lasting immunity.

Authors:  Lisa F Shubitz; Daniel A Powell; Hien T Trinh; M Lourdes Lewis; Marc J Orbach; Jeffrey A Frelinger; John N Galgiani
Journal:  Vaccine       Date:  2018-04-30       Impact factor: 3.641

5.  Glucan-Chitin Particles Enhance Th17 Response and Improve Protective Efficacy of a Multivalent Antigen (rCpa1) against Pulmonary Coccidioides posadasii Infection.

Authors:  Chiung-Yu Hung; Hao Zhang; Natalia Castro-Lopez; Gary R Ostroff; Payam Khoshlenar; Ambily Abraham; Garry T Cole; Austin Negron; Thomas Forsthuber; Tao Peng; John N Galgiani; Neil M Ampel; Jieh-Juen Yu
Journal:  Infect Immun       Date:  2018-10-25       Impact factor: 3.441

Review 6.  Helper T-cell responses and pulmonary fungal infections.

Authors:  Andrew J McDermott; Bruce S Klein
Journal:  Immunology       Date:  2018-06-14       Impact factor: 7.215

7.  A chromosomal-level reference genome of the widely utilized Coccidioides posadasii laboratory strain "Silveira".

Authors:  Marcus de Melo Teixeira; Jason E Stajich; Jason W Sahl; George R Thompson; Rachel B Brem; Claire A Dubin; Austin V Blackmon; Heather L Mead; Paul Keim; Bridget M Barker
Journal:  G3 (Bethesda)       Date:  2022-04-04       Impact factor: 3.154

Review 8.  Coccidioides immitis and posadasii; A review of their biology, genomics, pathogenesis, and host immunity.

Authors:  Theo N Kirkland; Joshua Fierer
Journal:  Virulence       Date:  2018       Impact factor: 5.882

Review 9.  The Known Unknowns of the Immune Response to Coccidioides.

Authors:  Rebecca A Ward; George R Thompson; Alexandra-Chloé Villani; Bo Li; Michael K Mansour; Marcel Wuethrich; Jenny M Tam; Bruce S Klein; Jatin M Vyas
Journal:  J Fungi (Basel)       Date:  2021-05-11

Review 10.  The Quest for a Vaccine Against Coccidioidomycosis: A Neglected Disease of the Americas.

Authors:  Theo N Kirkland
Journal:  J Fungi (Basel)       Date:  2016-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.